SouthState Corp’s iShares Biotechnology ETF IBB Stock Holding History

SouthState Corp’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.6K	Sell	82 -46	-36%	-$7.91K	﹤0.01%	633
2026 Q1	$21.6K	Hold	128	–	–	﹤0.01%	555
2025 Q4	$21.6K	Hold	128	–	–	﹤0.01%	567
2025 Q3	$18.5K	Sell	128 -175	-58%	-$23.9K	﹤0.01%	579
2025 Q2	$38.3K	Hold	303	–	–	﹤0.01%	542
2025 Q1	$38.8K	Buy	303 +221	+270%	+$30K	﹤0.01%	571
2024 Q4	$10.8K	Hold	82	–	–	﹤0.01%	491
2024 Q3	$11.9K	Hold	82	–	–	﹤0.01%	469
2024 Q2	$11.3K	Hold	82	–	–	﹤0.01%	481
2024 Q1	$11.3K	Hold	82	–	–	﹤0.01%	495
2023 Q4	$11.1K	Hold	82	–	–	﹤0.01%	460
2023 Q3	$10K	Hold	82	–	–	﹤0.01%	469
2023 Q2	$10.4K	Hold	82	–	–	﹤0.01%	468
2023 Q1	$10.6K	Hold	82	–	–	﹤0.01%	501
2022 Q4	$10.8K	Sell	82 -250	-75%	-$32.3K	﹤0.01%	552
2022 Q3	$39K	Sell	332 -110	-25%	-$13.7K	﹤0.01%	408
2022 Q2	$52K	Buy	442 +62	+16%	+$7.36K	﹤0.01%	397
2022 Q1	$50K	Buy	380 +48	+14%	+$6.25K	﹤0.01%	433
2021 Q4	$51K	Hold	332	–	–	﹤0.01%	396
2021 Q3	$53K	Hold	332	–	–	﹤0.01%	354
2021 Q2	$54K	Hold	332	–	–	﹤0.01%	292
2021 Q1	$50K	Hold	332	–	–	﹤0.01%	286
2020 Q4	$50K	Hold	332	–	–	﹤0.01%	280
2020 Q3	$45K	Buy	332 +82	+33%	+$11.1K	﹤0.01%	277
2020 Q2	$34K	Sell	250 -82	-25%	-$10.5K	﹤0.01%	229
2020 Q1	$36K	Buy	332 +31	+10%	+$3.57K	0.01%	221
2019 Q4	$36K	Hold	301	–	–	﹤0.01%	244
2019 Q3	$30K	Sell	301 -260	-46%	-$27.2K	﹤0.01%	235
2019 Q2	$61K	Buy	+561	New	+$59.7K	0.01%	243

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

SouthState Corp's IBB Position: Q2 2026 in Review

SouthState Corp reduced its iShares Biotechnology ETF (IBB) stake by 36% in Q2 2026, selling an estimated $7.91K and leaving 82 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #633.

SouthState Corp first reported a position in IBB in Q2 2019 and has held it in 29 quarters since. The position peaked at $61K in Q2 2019. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

SouthState Corp held 82 shares of iShares Biotechnology ETF worth $15.6K as of Q2 2026.
SouthState Corp sold 46 iShares Biotechnology ETF shares in Q2 2026, an estimated $7.91K.
iShares Biotechnology ETF made up ﹤0.01% of SouthState Corp's portfolio in Q2 2026, its #633 holding.
SouthState Corp first reported a position in iShares Biotechnology ETF in Q2 2019 and has held it in 29 quarters since.
SouthState Corp's iShares Biotechnology ETF position peaked at $61K in Q2 2019.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.